GlassScriptPhysician profile
Kathryn Gollotto
NPI 1730302274
$3,538.97
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,096 · 2020: $197 · 2021: $65.09 · 2022: $101 · 2023: $28.50 · 2024: $52.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,926.50 | 2019 | |
| Liberty Surgical INC. | $976.08 | 2019 | |
| Horizon Therapeutics Plc | $140.46 | 2020-2021 | |
| Bioventus LLC | $85.84 | 2020-2022 | |
| Depuy Synthes Sales INC. | $74.29 | 2019-2023 | Orthovisc, Monovisc |
| Fidia Pharma USA INC. | $59.61 | 2019 | |
| Djo, LLC | $52.25 | 2024 | Donjoy |
| Amgen INC. | $50.74 | 2019-2020 | |
| Hydrocision, INC. | $49.59 | 2019 | |
| Allergan, INC. | $35.58 | 2019-2022 | |
| Abbvie INC. | $24.02 | 2022 | |
| Stryker Corporation | $19.25 | 2022 | |
| Synergy Orthopedics, LLC | $18.03 | 2019 | |
| Pfizer INC. | $13.40 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Gollotto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.